Metacon Q2 revenue misses estimates despite 15% growth
Company’s quarterly revenue fell short of analyst forecasts even as sales rose 15% year-over-year. Shares slipped on the shortfall.
Metacon reported second-quarter revenue of $124.3 million, a 15% increase from $108.1 million in the same period last year, but fell below the $130.2 million consensus estimate compiled by Refinitiv. The company cited supply chain constraints and softer demand in key markets as factors tempering growth.
Net income rose to $18.7 million from $15.9 million a year earlier, driven by cost controls and higher margins in its specialty chemicals segment. Operating cash flow increased to $22.4 million, up from $19.8 million in Q2 2023.
Shares of Metacon fell 3.2% in pre-market trading following the release, extending losses from the prior session. Analysts at Jefferies maintained a hold rating but trimmed the price target to $42 from $45, citing macroeconomic headwinds and competitive pressures.
The company reaffirmed its full-year guidance, projecting revenue between $510 million and $530 million and adjusted EBITDA of $95 million to $105 million. Metacon’s CEO stated that while near-term challenges persist, long-term demand for its products remains robust.
Investor sentiment has been mixed as the specialty chemicals sector faces volatility from fluctuating raw material costs and regulatory changes in Europe and North America.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Mehr von Priya Anand →